HR 5150
115th Congress
House
Health
Business records
Civil actions and liability
Congressional oversight
Government studies and investigations
Health care costs and insurance
Inflation and prices
Manufacturing
Medicare
Prescription drugs
Protecting Medicare from Excessive Price Increases Act of 2018
Introduced: March 1, 2018
See on congress.gov
Everywhere this bill has been
4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 9, 2018
Referred to the Subcommittee on Health.
Mar 2, 2018
Referred to the Subcommittee on Health.
Mar 1, 2018
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Mar 1, 2018
Introduced in House
Plain-English summary
Protecting Medicare from Excessive Price Increases Act of 2018
This bill requires a drug manufacturer to pay a Medicare rebate on a single-source drug or biological in accordance with the extent to which the manufacturer's average sales price for the drug or biological increases faster than inflation.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
4
Cosponsors
1